Brexit - Updated Guidance for Veterinary Medicinal Products Approved via MRP/DCP

News Category: Regulatory news

Date: 18/12/2020

The HPRA would like to inform stakeholders that the Practical guidance for procedures related to Brexit for veterinary medicinal products approved via MR/DC procedures and the Practical guidance on the implementation of the Protocol on Ireland/Northern Ireland for veterinary medicinal products approved via MRP/DCP have been updated/published on the CMDv website dated December 2020.

These documents reflect the current position for MRP/DCP products, and should be consulted in advance of submitting related Brexit queries to vetinfo@hpra.ie



« Back